Entrada Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €181.82M +63.4% €56.61M -1,081.7% 31.1% +0.36 pp -€33.12M -126.4% -18.2% -1.3 pp
    €111.29M +∞% -€5.77M -92.4% -5.2% -0.052 pp €125.44M -260.0% 112.7% +1.1 pp
    €0.00 +NaN% -€75.44M +74.7% N/A -€78.41M +96.4% N/A
    €0.00 +NaN% -€43.19M +89.8% N/A -€39.92M +99.1% N/A
    €0.00 +NaN% -€22.75M +467.4% N/A -€20.05M +128.5% N/A
    €0.00 -€4.01M N/A -€8.77M N/A

    Notifications